METABOLIC IMMUNODEPRESSION AND METABOLIC IMMUNOTHERAPY - AN ATTEMPT OF IMPROVEMENT IN IMMUNOLOGICAL RESPONSE IN BREAST-CANCER PATIENTS BY CORRECTION OF METABOLIC DISTURBANCES

被引：35

作者：

DILMAN, VM

BERSTEIN, LM

OSTROUMOVA, MN

FEDOROV, SN

POROSHINA, TE

TSYRLINA, EV

BUSLAEVA, VP

SEMIGLAZOV, VF

SELEZNEV, IK

BOBROV, YF

VASILYEVA, IA

KONDRATJEV, VB

NEMIROVSKY, VS

NIKIFOROV, YF

机构：

来源：

ONCOLOGY | 1982年 / 39卷 / 01期

关键词：

D O I：

10.1159/000225596

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：13 / 19

页数：7

共 35 条

[1] ADJUVANT TREATMENT WITH LEVAMISOLE IN CANCER - REVIEW OF EXPERIMENTAL AND CLINICAL DATA [J].

AMERY, WK ;

SPREAFICO, F ;

ROJAS, AF ;

DENISSEN, E ;

CHIRIGOS, MA .

CANCER TREATMENT REVIEWS, 1977, 4 (03) :167-194

[2]

BAR RS, 1976, DIABETES, V25, P348

[3]

Burnet M, 1973, Triangle, V12, P159

[4]

CATALONA WJ, 1972, NEW ENGL J MED, V286, P1162

[5] ENHANCEMENT OF ANTITUMOR EFFECT OF 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA (BCNU) BY PHENYLETHYLBIGUANIDE (PHENFORMIN) [J].

COHEN, MH ;

STRAUSS, BL .

ONCOLOGY, 1976, 33 (5-6) :257-259

[6] IMMUNOLOGICAL ASPECTS OF HOST-RESISTANCE TO DEVELOPMENT AND GROWTH OF CANCER [J].

CURRIE, G .

BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 458 (02) :135-165

[7] IDENTIFICATION OF A LYMPHOCYTE SURFACE RECEPTOR FOR LOW-DENSITY LIPOPROTEIN INHIBITOR, AN IMMUNOREGULATORY SPECIES OF NORMAL HUMAN-SERUM LOW-DENSITY LIPOPROTEIN [J].

CURTISS, LK ;

EDGINGTON, TS .

JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (05) :1298-1308

[8] SULFATION FACTOR ACTIVITY OF SERA FROM PATIENTS WITH PITUITARY DISORDERS [J].

DAUGHADAY, WH ;

SALMON, WD ;

ALEXANDER, F .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1959, 19 (07) :743-758

[9]

Dilman V, 1979, SEROTONIN HLTH DIS, V5, P111

[10]

DILMAN VM, 1978, ARCH GESCHWULSTFORSC, V48, P1

← 1 2 3 4 →